Head of global research and development at Life Technologies
Partner at New Enterprise Associates
Medical College of Wisconsin director of research commercialization
Founder and Managing Partner, Frazier Healthcare Ventures
Connect has arranged a talk by Matthias von Herrath of the La Jolla Institute for Allergy & Immunology about his research into Type 1 diabetes, and his pursuit of a cure. Von Herrath has been recruited to lead a new translational diabetes center to be opened this summer in Seattle by Novo Nordisk. He plans to play a key role in clinical trials on potential new treatments for Type 1 diabetes, while continuing to lead his research program at the La Jolla Institute on a part-time basis. More information and online registration is here.